Research Paper Volume 12, Issue 8 pp 7129—7162

Therapeutic options for advanced epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer: a Bayesian network secondary analysis

class="figure-viewer-img"

Figure 2. Meta-analysis of efficacy for OS at the individual-treatment level. (A) Descriptions of the individual treatments included in this analysis. (B) Network plots showing comparisons between nodes (yellow circles), each representing a unique individual treatment. Each line corresponds to direct comparisons between treatments, with the width corresponding to the number of direct within-trial comparisons. (C) Comparison results of the most efficacious treatments and placebo (HR (95% CrI)). Each result is a comparison between the column-defining drug and the row-defining treatment. (D) Schematic detailing the most efficacious treatments according to the rankograms.